Geron (GERN) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free GERN Stock Alerts $3.35 -0.13 (-3.74%) (As of 05/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 3:44 PM | marketbeat.comGeron (NASDAQ:GERN) Trading Down 4.9%Geron (NASDAQ:GERN) Shares Down 4.9%May 27 at 4:19 AM | marketbeat.comSwiss National Bank Sells 232,900 Shares of Geron Co. (NASDAQ:GERN)Swiss National Bank cut its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 23.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 773,600 shares of the biopharmaceutical company's stock afteMay 25, 2024 | americanbankingnews.comGeron (NASDAQ:GERN) Stock Price Passes Above 200-Day Moving Average of $2.57May 23, 2024 | seekingalpha.comGeron Corporation: A High-Risk Deal With A Good Chance Of SuccessMay 19, 2024 | americanbankingnews.comGeron (NASDAQ:GERN) Shares Down 3.6% May 16, 2024 | businesswire.comGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 14, 2024 | marketbeat.comRussell Investments Group Ltd. Boosts Stake in Geron Co. (NASDAQ:GERN)Russell Investments Group Ltd. raised its position in Geron Co. (NASDAQ:GERN - Free Report) by 19.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,237,234 shares of the biopharmaceutical company'May 9, 2024 | marketbeat.comVivo Capital LLC Has $50.94 Million Stake in Geron Co. (NASDAQ:GERN)Vivo Capital LLC lifted its position in shares of Geron Co. (NASDAQ:GERN - Free Report) by 46.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 24,143,681 shares of the biopharmaceutical company's stock after acquiring an additional 7,619,047 shares duringMay 6, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Price Down 4.3%Geron (NASDAQ:GERN) Trading Down 4.3%May 3, 2024 | finance.yahoo.comGeron Corporation (NASDAQ:GERN) Q1 2024 Earnings Call TranscriptMay 3, 2024 | markets.businessinsider.comBuy Rating Affirmed: Anticipating Imetelstat’s Approval and Market PotentialMay 3, 2024 | finance.yahoo.comGeron Corp (GERN) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves and Financial HealthMay 3, 2024 | finance.yahoo.comThis Is Why Geron Corporation's (NASDAQ:GERN) CEO Compensation Looks AppropriateMay 3, 2024 | finance.yahoo.comQ1 2024 Geron Corp Earnings CallMay 3, 2024 | fool.comGeron (GERN) Q1 2024 Earnings Call TranscriptMay 2, 2024 | markets.businessinsider.comBuy Rating Affirmed for Geron Amid Positive Imetelstat Launch Prospects and Strong FinancialsMay 2, 2024 | markets.businessinsider.comGeron Corporation Q1 Loss increases, but beats estimatesMay 2, 2024 | marketbeat.comGeron (NASDAQ:GERN) Given Buy Rating at Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and set a $5.00 price target on shares of Geron in a report on Thursday.May 2, 2024 | investorplace.comGERN Stock Earnings: Geron Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | finance.yahoo.comEx-day dividend payment of AB Rokiškio sūrisMay 2, 2024 | businesswire.comGeron Corporation Reports First Quarter 2024 Financial Results and Business HighlightsMay 2, 2024 | investorplace.comThe Top 3 Penny Stocks to Buy in April 2024May 1, 2024 | marketbeat.comShort Interest in Geron Co. (NASDAQ:GERN) Grows By 5.9%Geron Co. (NASDAQ:GERN - Get Free Report) was the recipient of a significant increase in short interest during the month of April. As of April 15th, there was short interest totalling 49,420,000 shares, an increase of 5.9% from the March 31st total of 46,660,000 shares. Based on an average daily trading volume, of 12,430,000 shares, the days-to-cover ratio is currently 4.0 days.May 1, 2024 | seekingalpha.comGeron: FDA PDUFA Review With Continued Imetelstat AdvancementMay 1, 2024 | msn.comBaird Downgrades Geron (GERN)April 30, 2024 | msn.comBaird downgrades Geron to neutral, cites valuation concernsApril 30, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Dyne Therapeutics (DYN) and Geron (GERN)April 30, 2024 | msn.comTD Cowen Initiates Coverage of Geron (GERN) with Buy RecommendationApril 30, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Rating Lowered by Robert W. BairdRobert W. Baird downgraded Geron from an "outperform" rating to a "neutral" rating and set a $4.50 price target on the stock. in a report on Tuesday.April 29, 2024 | msn.comTD Cowen starts Geron at buy, cites imetelstat market potentialApril 29, 2024 | marketbeat.comGeron (NASDAQ:GERN) Hits New 12-Month High at $4.05Geron (NASDAQ:GERN) Hits New 12-Month High at $4.05April 29, 2024 | benzinga.comNavigating 10 Analyst Ratings For GeronApril 29, 2024 | marketbeat.comTD Cowen Initiates Coverage on Geron (NASDAQ:GERN)TD Cowen started coverage on shares of Geron in a research note on Monday. They issued a "buy" rating and a $10.00 price objective on the stock.April 27, 2024 | marketbeat.comVivo Capital LLC Has $89.84 Million Stock Holdings in Geron Co. (NASDAQ:GERN)Vivo Capital LLC grew its position in Geron Co. (NASDAQ:GERN - Free Report) by 12.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 27,225,292 shares of the biopharmaceutical company's stock after acquirApril 26, 2024 | marketbeat.comGeron (GERN) Scheduled to Post Earnings on ThursdayGeron (NASDAQ:GERN) will be releasing earnings before the market opens on Thursday, May 2, Zacks reports.April 25, 2024 | businesswire.comGeron to Announce First Quarter 2024 Financial Results on May 2, 2024April 24, 2024 | marketbeat.comGeron (NASDAQ:GERN) Shares Up 4.6%Geron (NASDAQ:GERN) Shares Up 4.6%April 24, 2024 | investorplace.com3 Red-Hot Biotech Rockets Blasting Off in 2024April 23, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Price Down 4%Geron (NASDAQ:GERN) Trading Down 4%April 18, 2024 | businesswire.comGeron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 17, 2024 | marketbeat.comGeron (NASDAQ:GERN) Stock Price Up 4.7%Geron (NASDAQ:GERN) Trading 4.7% HigherApril 15, 2024 | marketbeat.comGeron Co. (NASDAQ:GERN) Short Interest Down 8.4% in MarchGeron Co. (NASDAQ:GERN - Get Free Report) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 46,660,000 shares, a decline of 8.4% from the March 15th total of 50,950,000 shares. Based on an average daily trading volume, of 11,240,000 shares, the days-to-cover ratio is presently 4.2 days.April 11, 2024 | seekingalpha.comConsidering The Merits Of A Gamble On Geron CorporationApril 11, 2024 | marketbeat.comGeron (NASDAQ:GERN) Reaches New 52-Week High at $3.77Geron (NASDAQ:GERN) Reaches New 12-Month High at $3.77April 11, 2024 | markets.businessinsider.comBuy Rating Affirmed for Geron Following Insightful Leadership Discussion and Promising Drug Development ProgressApril 11, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Carl Zeiss Meditec (GB:0DHC), Geron (GERN) and Zur Rose Group AG (Six Swiss: CH:DOCM)April 11, 2024 | finance.yahoo.comGeron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near FutureApril 10, 2024 | marketbeat.comGeron (NASDAQ:GERN) Trading Up 2.3%Geron (NASDAQ:GERN) Trading Up 2.3%April 10, 2024 | marketbeat.comGeron (NASDAQ:GERN) Rating Reiterated by WedbushWedbush reissued an "outperform" rating and issued a $6.00 target price on shares of Geron in a research note on Wednesday.April 3, 2024 | businesswire.comGeron to Participate at Upcoming Investor Conferences in April Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Did You Get Your Free Bitcoin Yet? (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here GERN Media Mentions By Week GERN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GERN News Sentiment▼1.350.79▲Average Medical News Sentiment GERN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GERN Articles This Week▼64▲GERN Articles Average Week Get Geron News Delivered to You Automatically Sign up to receive the latest news and ratings for GERN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ORGO News Today INZY News Today FHTX News Today EXEL News Today HALO News Today IONS News Today MDGL News Today ALKS News Today FOLD News Today CLDX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GERN) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersA once-in-a-century investment opportunityStansberry ResearchThe #1 Crypto That You Don’t Own… YetCrypto 101 Media4 Cryptos BETTER than BitcoinTrue Market InsidersWrite this ticker symbol down…StocksToTradeYou won't believe what Citigroup just did to it's depositorsAmerican AlternativeMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Geron Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
